Using transient transfection assays, regulation properties of varicella-zoster virus (VZV)-encoded IE63 protein were analyzed on several VZV immediate early (ORF4), early (ORF28) and late (ORF67) promoters. IE63 was shown to repress the basal activity of most of the promoters tested in epithelial (Vero) and neuronal (ND7) cells to various extents. Trans-repressing activities were also observed on heterologous viral and cellular promoters. Since a construct carrying only a TATA box sequence and a series of wild-type or mutated interleukin (IL)-8 promoters was also repressed by IE63, the role of upstream regulatory elements was ruled out. Importantly, the basal activity of a TATA-less promoter was not affected by IE63. Using a series of IE63 deletion constructs, amino acids 151-213 were shown to be essential to the transrepressing activity in Vero cells, while in ND7 cells the essential region extended to a much larger carboxy-terminal part of the protein. We also demonstrate that IE63 is capable of disrupting the transcriptional pre-initiation complex and of interacting with several general transcription factors. The central and carboxy-terminal domains of IE63 are important for these effects. Altogether, these results demonstrate that IE63 protein is a transcriptional repressor whose activity is directed towards general transcription factors.
Introduction
Varicella-zoster virus (VZV) is a human a-herpes virus that causes chickenpox (varicella) and becomes latent in dorsal root ganglia (DRG). Upon reactivation from latency, VZV is responsible for zoster (shingles). The VZV genome is a double-stranded DNA molecule composed of 71 open reading frames (ORFs) encoding 68 proteins that seem to be regulated in a manner similar to other aherpes viruses. After entry into cells, VZV genes are expressed in a temporal cascade. The immediate early (IE) genes are expressed first. They stimulate early (E) gene expression, providing most of the proteins necessary for viral DNA replication. After DNA synthesis has occurred, genes of the late (L) class encoding structural proteins are expressed. In contrast to herpes simplex virus type 1 (HSV-1), VZV latency is characterized by the expression of several IE (ORFs 4, 62 and 63) and E (ORFs 21, 29, 66) genes (Meier et al., 1993; Cohrs et al., 1996 Cohrs et al., , 2003 Mahalingam et al., 1996; Grinfeld and Kennedy, 2004) . However, the biochemical and molecular processes controlling latency and reactivation of VZV are still largely unknown.
VZV open reading frames 63 and 70 (ORF63/70) encode a 278-amino-acid-long protein with a predicted molecular mass of 30.5 kDa but produce an extensively modified 45-kDa protein in infected cells (Debrus et al., 1995) . ORF63 is expressed as an IE protein (IE63) and exhibits a limited homology with the HSV-1 IE protein ICP22 (Davison and McGeoch, 1986; Davison and Scott, 1986 ) and the EHV-1 EICP22 protein (Derbigny et al., 2000) . IE63 most closely resembles HSV-1 Us1.5, which is a 274-amino-acid protein encoded by a gene that is co-linear with HSV-1 ICP22 (Baiker et al., 2004) .
IE63 is of particular interest in VZV pathogenesis since it is abundantly expressed during acute infection, as well as during latency (Debrus et al., 1995; Mahalingam et al., 1996; Kennedy et al., 2000; Grinfeld and Kennedy, 2004) . During lytic infection, its localization is mostly nuclear but it can also be faintly detected in the cytoplasm. However, during latency IE63 is almost exclusively localized in the cytoplasm of infected neuronal cells (Mahalingam et al., 1996; Lungu et al., 1998; Grinfeld and Kennedy, 2004) . IE63 protein interacts with VZV IE62 protein (Lynch et al., 2002; Baiker et al., 2004) and is essential for VZV replication (Sommer et al., 2001; Baiker et al., 2004) and latency (Cohen et al., 2004) .
Transcription of viral genes during a productive infection is mediated by interaction between viral activator or repressor proteins and various components of the cellular transcription machinery. This interaction is important for increasing or decreasing assembly of the preinitiation complex (PIC) necessary for transcription of genes by RNA polymerase II (RNA POL II). Activators or repressors may act directly or indirectly on PIC formation. The PIC is composed of the RNA POL II and general transcription factors (GTFs) (for a recent review, see Hahn, 2004 ) that can be attached on promoter templates in vitro (Buratowski, 1994; Hampsey, 1998; Grondin and DeLuca, 2000) . In most cases, the recognition of promoters is mediated by transcription factor TFIID through the bind-ing of the TATA binding protein (TBP) subunit to TATA box elements. The action of several viral proteins has been shown to be directed toward the PIC assembly (Choy and Green, 1993; Manet et al., 1993; Gu et al., 1995; Long et al., 1999; Grondin and DeLuca, 2000; Jang et al., 2001; Huang and McCance, 2002; Kim et al., 2003) .
The gene regulatory properties of IE63 protein are not very well understood and remain controversial. Some authors have reported that IE63 protein could repress the VZV IE62 promoter and stimulate the VZV thymidine kinase promoter, but could not affect expression of late genes in Vero cells (Jackers et al., 1992) . Another team suggested that expressed under the control of its own promoter, IE63 did not exert any regulatory properties on IE, E and L genes in the same cell line (Kost et al., 1995) . Conversely, IE63 was shown to up-regulate the IE62 effect on VZV gI promoter in A3.01 cells, a CD4
q T-cell line, and to interact with VZV IE62 protein (Lynch et al., 2002) . Recently, IE63 has been shown to exert important trans-repressive properties on the VZV DNA polymerase gene (ORF28) promoter in both Vero and ND7 cells (Bontems et al., 2002) . Therefore, an extensive series of transient transfection studies were carried out to better understand IE63 gene regulatory properties and its mechanism of action. From the data presented in this paper, it appears that IE63 is capable of repressing the basal activity of several promoters and is able to interfere with components of the pre-initiation complex.
Results

IE63 is a transcriptional repressor targeting the TATA-box
For many years, the transcriptional regulatory properties of IE63 remained unclear, being described either as a transcriptional repressor or activator, depending on the promoter tested, or without any transcriptional effect (Jackers et al., 1992; Kost et al., 1995; Lynch et al., 2002) . Recently, it was unambiguously shown that IE63 represses transcription initiated from the promoter controlling the VZV DNA polymerase gene (Bontems et al., 2002) . To better characterize IE63 regulatory properties, we decided to extend this important observation to other VZV promoters and to compare IE63 activity in two cell lines in which VZV leads to either a productive (monkey kidney epithelial cells, Vero) or non-productive (immortalized rat sensory neurons, ND7) cycle (Bontems et al., 2002) . Vero and ND7 cells were transfected with a plasmid expressing IE63, together with various constructs (Figure 1 ) where the reporter gene was under the control of autologous, as schematically represented in Figure 2A , or heterologous viral and cellular promoters, as schematically represented in Figures 3A and 4A . Figure 2B ,C shows that in both Vero and ND7 cells, IE63 exerts transcriptional repression properties on autologous VZV promoters belonging to two classes: ORF4 (p4-Luc) which encodes a gene regulator expressed as an IE protein, and ORF 28 (pPOL-Luc) which encodes the viral DNA polymerase and is an E protein. The basal activity of these promoters was dose-dependently decreased with IE63 expression (pcDNA-IE63). IE63 did not show any repressive activity on the promoter belonging to the L class (p67-Luc) that controls expression of glycoprotein I ( Figure 2B ,C). The presence of IE63 expression in the two cell lines was detected by Western blot analysis (Figure 2B, C, lower part) .
To identify elements of these promoters that could help us to clarify the mechanism of repression mediated by IE63, sequence alignment analysis was carried out. The only motifs shared by these promoters were a TATA-box and the initiator element (InR), suggesting that IE63 could exert its repression on basal transcription initiation. A computer search for TATA-boxes was then carried out on the promoter sequences using three different programs (Figure 1 ). The scores were arbitrarily set on the same scale from 0 to 1, with 1 being the best score. TATAboxes of ORF4 (p4-Luc), ORF28 (pPOL-Luc), and ORF67 (p67-Luc) have previously been mapped (Ling et al., 1992; Kinchington et al., 1994; Meier et al., 1994; Kost et al., 1995) . As expected, sequence analysis of these three TATA-boxes revealed that ORF4 and 28 showed good scores, while the score of the ORF67 TATA box was much lower and could be classified as an atypical TATAbox ( Figure 1 ). We then extended the sequence analysis to other VZV promoters (Figure 1 ). Strikingly, one of the lowest scores was obtained for a TATA-box from the ORF63 promoter (p63-Luc) which apparently also had an atypical TATA-box (Figure 1 ). Transient transfection of Vero cells was therefore carried out with this promoter ( Figure 2D ). As shown in Figure 2D , IE63 exhibited lower repressing activity against its own promoter, either under an extended or a short (163 bp) version wp63(163-bp)-Lucx ( Figure 2A ). Similar behavior was observed in ND7 cells transfected with the extended version of the ORF63 promoter (data not shown).
We also analyzed different heterologous viral and cellular promoters known to have good TATA-boxes ( Figure  1 ). These were: the major IE promoter from human cytomegalovirus (CMV, pCMV-Luc; Foecking and Hofstetter, 1986 ) and the HSV-1 UL44 (gC, pEL-Pgc-Luc) promoter (Lium and Silverstein, 1997) . As expected, the scores obtained with the various programs were very close to 1 (Figure 1 ). The IE63 repression activity of these promoters was also examined (Figure 3) . In that respect, these two promoters also had basal activity down-regulated by IE63 in both Vero and ND7 cells ( Figure 3B,C) . The observation that both VZV and heterologous promoters could have their basal activity repressed by IE63 to a similar extent and independently of the cell type used is interesting information that clarifies the regulatory properties of this viral protein.
To clarify further the importance of TATA-box and/or InR elements in the repression mediated by IE63, we used a reporter plasmid with transcription under the control of a TATA-box (pFR-Luc). The scores obtained for this sequence were quite good (Figure 1 ). Figure 4B shows that IE63 reduced the activity of this promoter by approximately 60% in both Vero and ND7 cells, reinforcing the idea that IE63 targeted TATA-boxes and/or InR. To confirm that IE63 targets only the TATA-box motif, we analyzed the effect of IE63 on the human polymerase a promoter (ph.POLa-Luc) which lacks this motif but bears an InR ( Figure 4A,C) . As expected, no TATA-box motif within this promoter was detectable by computer analysis (Figure 1 ). Even without any detectable TATA-box, this promoter exhibited high basal activity. Although IE63 protein was dose-dependently expressed ( Figure 4C , lower part), the basal activity of the human polymerase a promoter was not decreased in both Vero and ND7 cells ( Figure 4C ). These results confirmed on the one hand that several upstream regulatory elements, such as AP-2, AP-1, EF2, SP1, ATF and the CAAT-box, were not involved in IE63 repression and, on the other hand, that IE63 protein targets only the TATA-box sequence. This experiment also ruled out the role of the InR sequence in IE63-mediated repression. The lack of importance of several upstream regulatory elements was further confirmed using various constructs of the cellular interleukin (IL)-8 promoter which has been very well characterized (Roebuck, 1999) . The wild-type version of the promoter was dose-dependently repressed in both cell lines (Figure 1 , Figure 4D ) and this repression was independent of the mutations of various upstream regulatory elements. This demonstrated that AP-1, NF-IL-6 and NF-kB elements were not required for IE63 activity.
IE63 central and carboxy-terminal domains are important for repression
Recently we showed that IE63 is a highly phosphorylated protein and that the phosphorylation sites situated in the carboxy-terminal regions are necessary for repression (Bontems et al., 2002) . To better characterize the IE63 domains that are important for repression, IE63 deletion mutants were constructed: (i) IE63D1-75, with the amino-terminal region removed; (ii) IE63D76-150, with the central region partly deleted; (iii) IE63D151-213, with the region rich in CK1-CK2 phosphorylation sites deleted; and (iv) IE63D214-278, with the carboxy-terminal domain containing two putative phosphorylation sites for CDK1 (Bontems et al., 2002; Baiker et al., 2004 ) and a nuclear localization signal removed ( Figure 5A ). Western blot analysis demonstrated that these mutant proteins were stably expressed after transfection of Vero ( Figure 5B) and ND7 ( Figure 5C ) with 1-3 mg of expression vectors.
It should be noted that the removal of domain 151-213 of IE63 modified the electrophoretic migration of the protein, which was somewhat smaller than expected (25 instead of 34 kDa) ( Figure 5B ). This is likely due to the removal of a domain that is known to be highly phosphorylated in the wild-type protein (Bontems et al., 2002) . Co-transfection of cells with wild-type IE63 or the deleted constructs and VZV DNA polymerase reporter vector (pPOL-Luc) led to unexpected results ( Figure 5D ,E). Indeed, in Vero cells, the removal of either the aminoterminal (IE63D1-75), the second (IE63D76-150) or the carboxy-terminal domain (IE63D214-278) of IE63 did not alter trans-repression activity on the ORF28 (pPOL-Luc) promoter ( Figure 5D ) in comparison with wild-type IE63. However, IE63 domain 3 was essential for repression, since its removal led to the loss of repressive activity of the protein. Surprisingly, even the basal activity of the promoter was increased with this construct. In ND7 cells, the pattern of repression obtained with these mutant proteins was not identical ( Figure 5E ). Proteins lacking domain 3 (IE63D150-213) or domain 4 (IE63D214-278) were less efficient in repressing the ORF28 promoter, (Kinchington et al., 1995) are shown at the IE4 promoter: SP1 binding site (GC box) and CAAT (CAAT box) binding site. (B-D) Effect of VZV IE63 protein on the VZV IE4 promoter (p4-Luc), VZV DNA polymerase promoter (ORF28, pPOL-Luc), VZV gI promoter (p67-Luc) and VZV ORF63 promoter wp63-Luc and p63(163-bp)-Lucx. Vero (B, D) or ND7 (C) cells were co-transfected with luciferase reporter plasmids and increasing concentrations of plasmids expressing IE63 (pcDNA-IE63) as described in the materials and methods section. Results are presented as a percentage of stimulation with respect to basal expression of the promoter used (100%). At least three independent experiments were conducted for each condition and standard errors of the mean are shown as error bars. The expression of IE63 protein was confirmed by Western blotting (panels B-D, lower part). *p-0.002; **pG0.002.
demonstrating the importance of the carboxy-terminal part of IE63 in this cell type ( Figure 5E ). Similar results were obtained with the IL-8 promoter (data not shown).
IE63 co-localizes in the cell nucleus with TFIIE
As it is likely that IE63 targets TATA-boxes, we decided to characterize the cellular localization of IE63 with a component of the basal transcription machinery. In the classical model of transcriptional pre-initiation complex assembly, the transcription factor TFIIE (composed of two subunits, TFIIEa and TFIIEb) binds the RNA POL II at a late stage of initiation. Therefore, TFIIE was a good marker for PIC localization in the cell nucleus. Confocal microscopy analysis was carried out on Vero and ND7 cells transfected with the various constructs leading to wild-type or mutant IE63 expression ( Figure 6 ). Co-localization between IE63 and endogenous TFIIEa subunit was analyzed using secondary antibodies linked to fluorescein (TFIIE, in green) and Texas red (IE63, in red) (Figure 6A to F) . IE63 wild-type protein was mainly observed in the nucleus of Vero and ND7 cells. As shown in Figure  6A ,B, both IE63 and TFIIE are perfectly localized in the nucleus of the two cell types, except in the nucleolus, where IE63 was absent. Even if these results on their own did not demonstrate the interaction between IE63 and TFIIE, they showed that these proteins exhibit very similar distribution in the nucleus. A similar co-localization was analyzed by Western blotting. Vero or ND7 cells were co-transfected with 2 mg of reporter plasmids (pPOL-Luc) with 1, 2, or 3 mg of pcDNA-IE63 wild-type plasmids or deletion constructs. Cells were harvested and then RIPA lysis was carried out. Cellular protein extracts were loaded on a 10% SDS-PAGE gel. After electrophoresis and transfer to a PVDF membrane, IE63 proteins were detected using a polyclonal antibody. Secondary antibodies used were coupled to peroxidase. The membranes were then developed with an ECL kit (Amersham Pharmacia). (D,E) Vero and ND7 cells were co-transfected with VZV DNA polymerase promoter reporter plasmid (pPol-Luc) with 1-3 mg of pcDNA-IE63 wild-type plasmids or deletion constructs (pcDNA-IE63wt, pcDNA-IE63D1-75, pcDNA-IE63D76-150, pcDNA-IE63D151-213, pcDNA-IE63D214-278) constructs. Results are presented as a percentage of stimulation with respect to basal expression of the promoter (reporter alone, 100%). Three different experiments or more were conducted, and standard errors of the mean are shown as error bars.
pattern was observed in cells expressing IE63D1-75 and IE63D76-150 (data not shown).
Analysis of the cells transfected with pcDNA-IE63D151-213 revealed that the mutant protein expressed was mainly localized in the nucleus ( Figure  6C,D) . However, significantly less IE63 co-localization with TFIIE was observed compared with the wild-type protein. In the case of IE63D214-278, due to removal of the nuclear localization signal, this protein was exclusively localized in the cytoplasm of the two cell lines (Figure 6E,F) . Surprisingly, although TFIIE was exclusively located in the nucleus for all conditions, a minor fraction of TFIIE could be detected in the cytoplasm of Vero cells expressing IE63D214-278 ( Figure 6E ). In that case, the two proteins were shown to co-localize. This observation suggests that IE63 could partly sequester TFIIE or other associated GTFs in this cellular compartment. In ND7 cells, IE63 was also mainly localized in the cytoplasm, but not TFIIE ( Figure 6F ). Importantly, IE63D214-278 and TFIIE were never co-localized in the nucleus of ND7 cells ( Figure 6F) . A positive control for nuclear co-localization under identical experimental conditions was carried out by co-transfecting IE63 and IE62 expression vectors in the two cell lines. IE62 was chosen, since it was previously shown that this protein is capable of interacting with IE63 (Lynch et al., 2002; Baiker et al., 2004) . As shown in Figure 6G ,H, IE62 (in green) and IE63 (in red) were detected in the cell nucleus and were perfectly colocalized.
IE63 disorganizes the transcriptional pre-initiation complex
We then decided to examine whether IE63 could influence the PIC assembly when formed on a DNA probe. In this respect, a PIC assembly assay (Grondin and DeLuca, 2000) was carried out involving a probe encompassing well-described transcription initiation sites (from HSV-1 gC or IL-8 promoters) bound to magnetic beads and extracts from Vero and ND7 cells, either transfected or not with an IE63 expression vector. After PIC formation, the DNA-protein complexes were extensively washed and analyzed by SDS-PAGE and silver-stained. Due to weak binding efficiency of the Vero cell extracts to the gC or IL-8 probes, these experiments were only carried out with ND7 cells. As shown in Figure 7A , SDS-PAGE analysis revealed several bands with a diminished intensity after IE63 expression (shown by arrows), whereas others were totally unchanged (shown by asterisks). Examples of putative GTFs that could correspond to proteins having a reduced band intensity are listed in Figure  7A : TFIIE subunits a (56 kDa) and b (34 kDa); RNA POL II subunits POLR2A (220 kDa) and POLR2C (33 kDa); TAFs TAF1 (250 kDa), TAF7 (55 kDa) and TAF10 (30 kDa); and TFIIH polypeptide 2 (44 kDa), polypeptide 3 (34 kDa) and TFIIB (33 kDa). The mean reduction in the amount of putative transcription factors by IE63 expression was calculated after gel photodensitometry: TAF1, 39%; POLR2A, 41%; TFIIEa, 18%; TFIIH2, 25%; and TFIIEb, 50%. It should be noted that no increase in the band intensity was observed after IE63 expression in ND7 cells. To identify the factors incorporated within the preinitiation complex for which the concentration was lowered by IE63 on the gC probe, Western blot analysis was carried out on several GTFs wRNA POL II, TFIIE, TFIIH, TFIID (TBP subunit) and TFIIBx and IE63. PIC assembly assays were carried out in parallel on nuclear proteins bound to the probe and taken from cells transfected either with an empty vector (pcDNA3.1 -) or with an IE63 expression vector (pcDNA-IE63) ( Figure 7B ). The protein input unbound to the probe ('not bound') was used as a positive control. The first important information obtained by Western blot analysis was that only a very marginal fraction of IE63 could be found associated to the basal transcription machinery, with the vast majority of IE63 found in the flow through. Among the factors associated with the pre-initiation complex, three of them (TFIIEa, TFIIH and TFIIB) showed lower concentrations when IE63 was expressed ( Figure 7B , central lane). The content of the RNA POL II large subunit (POLR2A) was also lowered, but to a lesser extent. Finally, TBP was unaffected by the presence of IE63. This last result could be explained by the weak interaction between these two proteins observed with a two-hybrid system (data not shown) and by the fact that TBP is buried inside the preinitiation complex with no external exposure. We also carried out a PIC assembly assay on the IL-8 probe and similar results were obtained (data not shown). Overall, these data demonstrate that IE63 is capable of interfering with several important factors of the transcriptional preinitiation complex and therefore explain why IE63 represses transcription.
To correlate the data obtained in transient transfection assays with the transcriptional PIC assembly, PIC assays were also carried out on extracts from ND7 cells transfected with plasmids expressing IE63 in which domains 3 or 4 were removed and then compared to wild-type IE63 or non-transfected cells ( Figure 7C ). Western blot analysis of the PIC content showed that TFIIE and TFIIB were not affected when domain 4 of IE63 was deleted ( Figure 7C, lane 4) . A slight decrease in the content of TFIIE was also observed with IE63 lacking domain 3 (Figure 7C ). This demonstrates that the region of IE63 encompassing most of the phosphorylation sites is crucial for removal of these factors. Again, the IE63 deletion mutants were stable and well expressed under these conditions and the level of TFIIE expressed was similar in cells that either expressed IE63 (wild-type or deletion mutants) or not ( Figure 7D ).
To further confirm IE63 interaction with several GTFs, immunoprecipitation assays of IE63 were carried out ( Figure 7E ). ND7 cells were transfected with pcDNA-IE63-IRES2-EGFP (allowing the expression of IE63 and GFP) and lysed 24 h later. Western blot analyses of the proteins immunoprecipitated with IE63 revealed the presence of TFIIH ( Figure 7E ). The presence of RNA POL II (POLR2A) and TFIIE in the immunoprecipitates could also be faintly detected ( Figure 7E ). As a control, IE63 was also revealed by Western blotting among the immunoprecipitated proteins. Conversely, TFIIH immunoprecipitation also allowed the detection of IE63 in the transfected cells ( Figure 7F) .
From these data, we can conclude that IE63 disorganizes the basal transcription initiation complex by interfering with the binding of several important GTFs on promoters through interaction with its phosphorylated domain, leading to repression of gene transcription.
Discussion
We have shown in this study that IE63 protein represses the basal activity of IE and E VZV promoters in a dosedependent manner. However, IE63 seems to repress the L promoter tested (gI promoter) and its own promoter to a far lesser extent. Heterologous promoters such as those controlling the CMV major IE gene and human IL-8 were also repressed. When all the promoter sequences used were analyzed, the only element common to the promoters tested was the TATA-box. Its importance for IE63 repression was demonstrated using promoters either bearing solely a TATA-box or having no TATA-box: IE63 efficiently repressed the first construct, while it had no effect on the second. In conclusion, IE63 was shown to be a transcriptional repressor acting on different promoters, but its efficiency depends on the presence and on the nature of the TATA-box. Several authors, including our group, have not always observed that this property of IE63 acts as a transcriptional repressor (Jackers et al., 1992; Kost et al., 1995; Lynch et al., 2002) . This can be explained by the use of less sensitive transfection technologies by several authors or by the suspicion that IE63 repressive activity cannot be observed in every cell type. By deletion analysis, we have also demonstrated that amino acids 151-213 of IE63 are essential for the repression activity in Vero cells. This domain of IE63 encompasses the S/T-rich region shown to be phosphorylated by both CK1 and -2. Therefore, it can be suspected that the active form of IE63 in these assays is the phosphorylated form. Unexpectedly, and for unknown reasons, the removal of this domain converts IE63 into a slight gene activator in Vero cells. In ND7 cells, the essential domain extended from the central part to the carboxyterminal end of the protein. This carboxy-terminal domain encompasses a nuclear localization signal and two amino acids (T222 and S224) that could be phosphorylated by CDK1. Therefore, we can suspect that in undifferentiated neuronal cells the phosphorylation of these two amino acids could be a pre-requisite for transcriptional repression.
Several authors have reported that viral proteins can interact with GTFs for gene trans-activation or repression (Gu et al., 1995; Carrozza and DeLuca, 1996; Kawaguchi et al., 1997; Hampsey, 1998; Long et al., 1999; Grondin and DeLuca, 2000; Jang et al., 2001; Kim et al., 2003) . Three different mechanisms of repression via the basal transcription machinery have been proposed (for a review, see Gaston and Jayaraman, 2003) . The first involves a modification of the RNA POL II large subunit C-terminal domain (CTD). It has been shown that HSV-1 ICP22 and UL13 are capable of altering RNA POL II CTD phosphorylation to promote late viral transcription (Long et al., 1999) . The second mechanism involves interference with the binding of TBP to the TATA-box, leading to a transcriptional repression. The adenovirus E1 protein represses transcription by making direct contact with TBP, which interferes with the formation of the TBP-TATA complex (Song et al., 1997) . Finally, a number of repressors either sequester GTFs or bind to GTF, creating steric hindrance that prevents correct PIC assembly. Our results reveal that this last mechanism may be applicable to IE63. The first step of PIC assembly is TBP fixation on the TATA-box. We looked at this step first and found that IE63 did not seem to be capable of targeting TBP. This was confirmed by the demonstration that (i) IE63 interacted poorly with TBP when using a two-hybrid system (data not shown) and (ii) TBP was not removed from immobilized promoters in the presence of IE63. However, the content of RNA POL II, TFIIB, TFIIE and TFIIH bound to the probe was altered by IE63. Immunoprecipitation experiments confirmed these effects. Indeed, TFIIH, and to a lesser extent TFIIE and RNA POL II, immunoprecipitated with IE63. Therefore, we believe that IE63 directly interacts with one of these proteins, leading to destabilization of the PIC and the removal of several GTFs from the promoter. This PIC destabilization explains how IE63 is a transcriptional repressor. These results confirmed those obtained using infected cells in which IE63 was found to immunoprecipitate with RNA POL II (Lynch et al., 2002) . Although the nature of the GTF(s) targeted by IE63 has not yet been unambiguously identified, it is obvious from the data presented above that IE63 sequestered one or several GTFs and in this way destabilized the PIC assembly. This hypothesis is reinforced by the observations made using confocal microscopy. Indeed, IE63 was always observed in the nucleus and co-localized with TFIIE, an important GTF. IE63 deleted of its region encompassing amino acids 151-213, important for repression, did not co-localize as clearly with TFIIE. Moreover, expression of the cytoplasmic mutant of IE63 (IE63D214-278) in Vero cells co-localized with a small fraction of TFIIE present in the cytoplasm. This unexpected finding suggests that even when present in the cytoplasm, IE63 could sequester a small fraction of neo-synthesized GTF(s), which could explain the preserved repression capacity of this deleted IE63 protein. The cytoplasmic sequestration of TFIIE seems to be a special feature of IE63 expressed in Vero cells, since TFIIE was never found in the cytoplasm of ND7 cells. Interestingly, promoter repression by the carboxy-terminal mutant of IE63 was partially lost in ND7 cells.
In summary, this study demonstrated that IE63 is a transcriptional repressor effective on every promoter bearing a good TATA-box consensus. The repression occurred after IE63 had disorganized formation of the pre-initiation complex by sequestering one or several GTFs. The capacity of IE63 to repress transcription has been observed in two different cell lines in which VZV has a productive (Vero) or a non-productive cycle (ND7), demonstrating that this property is independent of the cell type. However, this does not explain the non-productive infection observed in non-differentiated neuronal cells. To further clarify the role of IE63 in the latent infectious cycle, it would be interesting to analyze the repressive properties of this protein in differentiated neurons and to investigate the influence of phosphorylation by cellular kinases.
Materials and methods
Plasmids
IE63 activity on different promoters was analyzed using transient transfection assays. Reporter plasmids with the luciferase (Luc) gene are under the control of VZV or heterologous promoters using the pGL3-Basic vector (Promega, Leiden, The Netherlands): p4-Luc (VZV ORF4 promoter), pPOL-Luc (VZV ORF28), p67-Luc (VZV ORF67), and p63-Luc (VZV ORF63). To construct p4-Luc, the VZV ORF4 promoter was amplified by PCR from p4-CAT (Defechereux et al., 1993) and then cloned in the SmaI and BglII sites. pPOL-Luc was constructed as previously described (Bontems et al., 2002) . To obtain p67-Luc, the pgI-CAT plasmid (Ling et al., 1992) was digested using BglII to excise the VZV ORF67 promoter and cloned using the pGL3-Basic vector into the BglII sites. The p63-Luc plasmid was generated by inserting the intergenic region between ORF62 and ORF63 in the pGL3-basic vector. A shorter version containing 163 bp of the IE63 promoter driving luciferase gene was also used wp63(163-bp)-Lucx. pFR-Luc contains the luciferase gene and a TATA-box sequence (Stratagene, La Jolla, CA, USA). Plasmid pIL-8-Luc, a human IL-8 promoter fragment of 133 bp, and plasmid pIL-8-NF-kB-mut-Luc, a human IL-8 promoter fragment of 133 bp with the NF-kB site GGAATTTCCT (-80 to -71 bp) mutated to TAACTTTCCT. Plasmid pIL-8-AP-1-mut-Luc contained a human IL-8 promoter fragment of 133 bp with the AP-1 site TGACTCA (-126 to -120 bp) mutated to TATCTCA. Plasmid pIL-8-NF-IL-6-mut-Luc wcontaining a human IL-8 promoter fragment of 133 bp with the NF-IL6 site CAGTTGCAAATCGT (-94 to -81 bp) mutated to AGCTTGCAAATCGTx. All these IL-8-Luc plasmids were kindly provided by Dr. W. Vandenberghe and Dr. G. Haegeman (Ghent University, Ghent, Belgium). pEL-Pgc-Luc contains the promoter of the HSV-1 UL44 (gC) gene and the luciferase reporter gene (Lium and Silverstein, 1997) . Plasmid ph.POLa-Luc contains the human DNA polymerase a promoter and is described elsewhere (Moon et al., 2001; Truscott et al., 2003) . For the expression of IE63 or IE62, we cloned ORF63 or ORF62 (under the control of the CMV promoter) in pcDNA3.1 -(Invitrogen, Merelbeke, Belgium) in order to obtain pcDNA-IE63 (Bontems et al., 2002) or pcDNA-IE62. ORF63 was also cloned in pcDNA-IRES2-EGFP (BD Biosciences, Clontech, Erembodegem, Belgium) for dual expression of IE63 and EGFP (pcDNA-IE63-IRES2-EGFP). Four plasmids expressing IE63 deletion mutants were constructed by PCR from pcDNA-IE63. The first, pcDNA-IE63D1-75, led to the expression of IE63 lacking the first 75 amino acids. pc-DNAD75-150, pcDNAD151-213 and pcDNAD214-278 are plasmids that express IE63 deleted of amino acids was also cloned in frame with the amino c-myc tag in pCMV Tag3 (Stratagene) to obtain pmyc-IE63D214-278. All these expression constructions were sequenced.
TATA-box analysis
The promoter sequences tested were submitted to three different software programs that search for the core promoter and/or the TATA-box (the score was reported on a scale between 0.5 and 1.0): http://www.fruitfly.org/seq_tools/promoter.html (Reese et al., 1996) ; http://tfbind.ims.u-tokyo.ac.jp (Heinemeyer et al., 1998) ; and http://motif.genome.ad.jp/ (Heinemeyer et al., 1999) .
Antibodies
The antibodies used in this work are directed against IE63 (monoclonal and polyclonal; Debrus et al., 1995; Bontems et al., 2002; Kennedy et al., 2001) , TBP (polyclonal; Santa Cruz Biotechnology SC-273, Santa Cruz, CA, USA), TFIIB (monoclonal; Transduction Laboratories T41520, Nottingham, UK), TFIIEa (polyclonal; Santa Cruz Biotechnology SC-237), TFIIH-CDK7 (monoclonal; Santa Cruz Biotechnology SC-7344) and RNA POL II largest subunit (monoclonal; Santa Cruz Biotechnology SC-17798), c-Myc epitope (monoclonal; Santa Cruz Biotechnology SC-40), and IE62 (polyclonal; Baudoux et al., 1995) .
Cells
Vero cells (monkey kidney cell line, ATCC CCL-81) were grown in EMEM medium (Biowhittaker, Petit-Rechain, Belgium) supplemented with L-glutamine and 10% fetal bovine serum (Biowhittaker). ND7 cells (ECACC no. 92090903) were obtained from a fusion of murine neuroblastoma cells with primary nerve cells from rat dorsal root ganglia. They were grown in RPMI-1640 (Biowhittaker) supplemented with L-glutamine and 5% fetal bovine serum (Invitrogen) (Wood et al., 1990 ).
Cytoplasmic and nuclear protein extracts
Briefly, cells from confluent 175-cm 2 dishes were harvested, washed in cold phosphate-buffered saline (PBS; 137 mM NaCl, 8 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , 2.7 mM KCl, pH 7.4), pelleted and resuspended in 180 ml of cold hypotonic buffer I w10 mM HEPES-KOH, pH 7.9, 0.1 mM EDTA, 10 mM KCl, 2 mM MgCl 2 , 1 mM dithiothreitol (DTT), 0.5 mM phenylmethylsulfonyl fluoride (PMSF), 0.5% IGEPAL ᮋ CA-630; Sigma, Steinheim, Germany) and protease inhibitors (Complete Protease Inhibitors, Roche Molecular Biochemicals, Mannheim, Germany)x. The cells were then incubated for 15 min on ice, vortexed for 10 s and centrifuged for 30 s at 16 000 g. The supernatant corresponding to cytoplasmic extract was stored at -808C. The pellets were resuspended in 120 ml of hypertonic buffer II containing 50 mM HEPES-KOH, pH 7.9, 50 mM KCl, 300 mM NaCl, 1 mM DTT, 0.5 mM PMSF and protease inhibitors (Complete Protease Inhibitors, Roche Molecular Biochemicals). Cells were allowed to swell on ice for 30 min. After centrifugation (15 min at 20 000 g and 48C), the supernatant containing the nuclear proteins was stored at -808C. Protein concentrations were measured using the Bradford method (reagent from Bio-Rad, Nazareth, Belgium).
Total cellular protein extracts (RIPA lysis) and Western blot analysis
Total cellular extracts from Vero cells were obtained using a RIPA lysis buffer. Briefly, cells from 35-mm-diameter six-well cluster dishes were harvested, washed in PBS, pelleted and resuspended in 200 ml of RIPA lysis buffer wPBS supplemented with 1% Nonited P-40, 0.5% Tween 20, 0.1% (w/v) sodium dodecyl sulfate (SDS), 5 mM EDTA, 1 mM DTT, and protease inhibitors (Complete Protease Inhibitors, Roche Molecular Biochemicals)x. Cells were allowed to swell on ice for 30 min, vortexed, then transferred to ice for an additional 30 min, and centrifuged for 20 min at 20 000 g at 48C. Protein concentrations of the supernatants were measured using the Bradford method (reagent from Bio-Rad) and analyzed by Western blotting (15 mg of protein was loaded).
Transient transfection assays
Transfections were carried out with cells (Vero or ND7) seeded into 35-mm-diameter six-well cluster dishes using the FUGENE 6 transfectant reagent (Roche Molecular Biochemicals) according to the manufacturer's prescriptions. For each experiment, cells were co-transfected with 2 mg of luciferase reporter plasmids and 0-3 mg of IE63 expression plasmid (pcDNA-IE63) The amounts of DNA were adjusted with herring sperm DNA. Special care was taken to obtain an equimolar ratio of CMV promoters in each independent experiment. At 24 h post-transfection, cells were harvested and luciferase assays were carried out using the Luciferase Reporter Gene Assay, high sensitivity kit (Roche Molecular Biochemicals) according to the manufacturer's instructions. For each experiment, the protein concentration in each sample was measured to normalize the results. Data from luciferase assays were collected from at least three independent transfection experiments. p values were calculated using Graphpad Quickcalcs software (www.graphpad.com). To compare observed and expected means, a one-sample t-test was used. For comparison of two means, an unpaired t-test was chosen.
For Western blot analysis, 15 mg of protein extract (RIPA lysis) was loaded onto a 10% SDS-PAGE gel. After migration and transfer, detection of IE63 was carried out using a monoclonal antibody as previously described (Kennedy et al., 2001; Bontems et al., 2002) .
Confocal microscopy
Cells transfected by pcDNA-IE63 and grown on coverslips were rinsed with warm PBS and fixed with 4% (w/v) paraformaldehyde/PBS for 10 min at room temperature and 20 min at 378C. After washing with PBS, the cells were permeabilized with PBS containing 0.1% Triton X-100 for 10 min at room temperature and 20 min at 378C. Cells were then incubated with an endogenous rabbit serum anti-TFIIE antibody and a monoclonal anti-IE63 antibody (9A12) (Debrus et al., 1995) (to detect IE63wt, IE63D1-75, IE63D76-150 and IE63D151-213) or a monoclonal anti-c-myc antibody (for detection of IE63D214-278) in PBSq1% fetal bovine serum (FBS) for 1 h at 378C. After washing with PBSqFBS 1%, coverslips were incubated with fluorescein isothiocyanate (FITC)-conjugated anti-rabbit secondary antibodies (DAKO A/S, Heverlee, Belgium) and a Texas Red-conjugated anti-mouse secondary antibody (Molecular Probes, Leiden, The Netherlands) for 1 h at 378C. For IE62 and IE63 staining, cells were first co-transfected with the same amount of pcDNA-IE62 and pcDNA-IE63 expression plasmids. To detect IE62, polyclonal antibodies and then FITC-conjugated anti-rabbit secondary antibodies (DAKO A/S) were used. Staining for IE63 was the same as described above. Following a PBS rinse, coverslips were mounted with SlowFade Light Anti-fade reagent (Molecular Probes). Confocal microscopy analysis was carried out using a TCS SP confocal microscope (Leica, Campbell, CA, USA) as previously described (Vanderplasschen et al., 2000) . Pictures were collected using a 63= 0.9HCX APO L objective lens and electronic amplification giving rise to square pictures corresponding to 39.7=39.7 mm 2 of the specimen. Cross-talk was avoided by sequential acquisition of the green and red signals and by setting appropriate spectral windows. The absence of cross-talk between channels was demonstrated by the analysis of single positive specimens (data not shown).
PIC assembly assays
A 70-bp fragment of the HSV-1 gC (UL44) promoter and a 100-bp segment of the IL-8 promoter were synthesized and biotinylated (Eurogentec, Liè ge, Belgium) at the 59-end. The purified biotinylated promoters were then immobilized on a magnetic resin conjugated with streptavidin (Dynal, Compié gne, France) at 10 mg of DNA biotinylated per 200 mg of beads by assay. A 175-cm 2 T-flask containing cells was transfected with 24 mg of plasmids (pcDNA3.1-, pcDNA-IE63wt). Cells were treated for a period of 36 h with G418 (1 mg/ml; Invitrogen) in order to select only the transfected cells. Approximately 500 mg of the total cell extract (estimated by the Bradford assay) either containing IE63 protein or not was added to 50 mg of immobilized promoters in 400 ml of binding buffer as described by Grondin and DeLuca (2000) . The samples were then incubated for 1 h at room temperature on a rotating mixer. After incubation, the immobilized templates with the proteins were concentrated using a magnetic concentrator (Dynal), resuspended and washed five times in 400 ml of binding buffer. The whole samples were finally analyzed by Western blotting and silver staining (Invitrogen, SilverXpress) after SDS-PAGE on 10% or 12% gels. Silverstained gel densitometry was carried out using ImageQuant software.
Immunoprecipitations
Mouse monoclonal antibody against IE63 (9A12, 30 ml) and 30 ml of protein A-Sepharose (Amersham Pharmacia Biotech, Brecht-St. Lenaarts, Belgium) were incubated in buffer C (Yamamoto et al., 2001 ) w20 mM Tris-HCl (pH 7.9 at 48C), 0.5 mM EDTA, 20% (v/v) glycerol, 0.5 mM PMSF, 10 mM 2-mercaptoethanol, 0.002% (v/v) Nonidet P-40x containing 100 mM KCl (BC100) and 200 mg of bovine serum albumin (BSA)/ml for 2 h at 48C with rotation. The protein A-Sepharose beads were precipitated and washed twice with 1 ml of buffer C containing 0.5 M KCl (BC500) and twice again with 1 ml of BC100. ND7 cells transfected with pcDNA-IE63-IRES-EGFP or pcDNA-IRES-EFGP were lysed with protocole lysis using buffer I and buffer II (described above) containing 20% glycerol. Approximately 400 mg of cellular extracts was then incubated with the prepared anti-IE63 antibody-protein A beads in 1.5 ml of BC500 overnight at 48C with rotation. The beads were washed three times with 1 ml of BC500 and boiled in SDS sample buffer. The immunoprecipitated proteins released from the beads were then analyzed by Western blotting. The membranes were either cut into several pieces before incubation with the various antibodies or were reprobed.
